Literature DB >> 25710656

Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy.

Howard L McLeod1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25710656     DOI： 10.1001/jama.2015.1086

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  A novel diagnostic method for pituitary adenoma based on magnetic resonance imaging using a convolutional neural network.

Authors:  Yu Qian; Yue Qiu; Cheng-Cheng Li; Zhong-Yuan Wang; Bo-Wen Cao; Hong-Xin Huang; Yi-Hong Ni; Lu-Lu Chen; Jin-Yu Sun
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

2.  Assessing the readiness of precision medicine interoperabilty: An exploratory study of the National Institutes of Health genetic testing registry.

Authors:  Jay G Ronquillo; Chunhua Weng; William T Lester
Journal:  J Innov Health Inform       Date:  2017-11-17

Review 3.  Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.

Authors:  Qing-Yan Yang; Ya-Hui Hu; Hong-Li Guo; Ying Xia; Yong Zhang; Wei-Rong Fang; Yun-Man Li; Jing Xu; Feng Chen; Yong-Ren Wang; Teng-Fei Wang
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.